Cargando…
Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial
INTRODUCTION: Inflammation and myocardial damage caused by cardiovascular surgery with cardiopulmonary bypass (CPB) have been shown to be the major contributors to postoperative morbidity and mortality. Colchicine can reduce myocardial ischaemia-reperfusion injury in patients with chronic coronary a...
Autores principales: | Zhang, He, Han, Xikun, Pan, Tuo, Zhang, Hai-Tao, Zhong, Kai, Li, Ze-Shi, Jiang, Xinyi, Pan, Jun, Wang, Dong-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808419/ https://www.ncbi.nlm.nih.gov/pubmed/35105570 http://dx.doi.org/10.1136/bmjopen-2021-050577 |
Ejemplares similares
-
Diagnosis of infection after cardiovascular surgery (DICS): a study protocol for developing and validating a prediction model in prospective observational study
por: Zhang, Hai-Tao, et al.
Publicado: (2021) -
Central and Peripheral Cannulation for Cardiopulmonary Bypass in Fetal Sheep: A Comparative Study
por: Teng, Yun, et al.
Publicado: (2021) -
Colchicine for Coronary Artery Disease: A Review
por: Chen, Tao, et al.
Publicado: (2022) -
Nadir oxygen delivery is associated with postoperative acute kidney injury in low-weight infants undergoing cardiopulmonary bypass
por: Gao, Peng, et al.
Publicado: (2022) -
ΔPCO(2) and ΔPCO(2)/C((a−cv))O(2) Are Not Predictive of Organ Dysfunction After Cardiopulmonary Bypass
por: Zhang, Sheng, et al.
Publicado: (2021)